A 24‐Week , Phase IIa , Randomized, Double‐Blind , Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis
- Resource Type
- Source
- Arthritis & Rheumatology.
- Subject
Rheumatology Immunology Immunology and Allergy - Language
- ISSN
- 2326-5205
2326-5191